Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Jan 28, 2017 | $47.9B |
| FY2017, ended Feb 3, 2018 | $49.2B |
| FY2018, ended Feb 2, 2019 | $59.4B |
| FY2019, ended Feb 1, 2020 | $70.7B |
| FY2020, ended Jan 30, 2021 | $77.2B |
| FY2021, ended Jan 29, 2022 | $83.9B |
| FY2022, ended Jan 28, 2023 | $94.4B |
| FY2023, ended Feb 3, 2024 | $110B |
| FY2024, ended Feb 1, 2025 | $139B |
| FY2025, ended Jan 31, 2026 | $166B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $173B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Jan 28, 2017 | $33.2B |
| FY2017, ended Feb 3, 2018 | $35.9B |
| FY2018, ended Feb 2, 2019 | $39.0B |
| FY2019, ended Feb 1, 2020 | $41.7B |
| FY2020, ended Jan 30, 2021 | $32.1B |
| FY2021, ended Jan 29, 2022 | $48.5B |
| FY2022, ended Jan 28, 2023 | $49.9B |
| FY2023, ended Feb 3, 2024 | $54.2B |
| FY2024, ended Feb 1, 2025 | $56.4B |
| FY2025, ended Jan 31, 2026 | $60.4B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $62.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Jan 28, 2017 | $2.30B | $2.60B |
| FY2017, ended Feb 3, 2018 | $2.61B | $1.97B |
| FY2018, ended Feb 2, 2019 | $3.06B | $2.96B |
| FY2019, ended Feb 1, 2020 | $3.27B | $2.84B |
| FY2020, ended Jan 30, 2021 | $90.0M | $3.99B |
| FY2021, ended Jan 29, 2022 | $3.28B | $2.01B |
| FY2022, ended Jan 28, 2023 | $3.50B | $2.63B |
| FY2023, ended Feb 3, 2024 | $4.47B | $4.33B |
| FY2024, ended Feb 1, 2025 | $4.86B | $4.20B |
| FY2025, ended Jan 31, 2026 | $5.49B | $4.92B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $6.07B | $5.88B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Jan 28, 2017 | $2.93B |
| FY2017, ended Feb 3, 2018 | $2.76B |
| FY2018, ended Feb 2, 2019 | $3.03B |
| FY2019, ended Feb 1, 2020 | $3.22B |
| FY2020, ended Jan 30, 2021 | $10.5B |
| FY2021, ended Jan 29, 2022 | $6.23B |
| FY2022, ended Jan 28, 2023 | $5.48B |
| FY2023, ended Feb 3, 2024 | $5.60B |
| FY2024, ended Feb 1, 2025 | $5.33B |
| FY2025, ended Jan 31, 2026 | $6.23B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $6.00B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Jan 28, 2017 | $2.23B |
| FY2017, ended Feb 3, 2018 | $2.23B |
| FY2018, ended Feb 2, 2019 | $2.23B |
| FY2019, ended Feb 1, 2020 | $2.24B |
| FY2020, ended Jan 30, 2021 | $6.08B |
| FY2021, ended Jan 29, 2022 | $3.35B |
| FY2022, ended Jan 28, 2023 | $3.36B |
| FY2023, ended Feb 3, 2024 | $2.86B |
| FY2024, ended Feb 1, 2025 | $2.87B |
| FY2025, ended Jan 31, 2026 | $2.87B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $2.87B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 14.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Jan 28, 2017 | 1.29B |
| FY2017, ended Feb 3, 2018 | 1.25B |
| FY2018, ended Feb 2, 2019 | 1.21B |
| FY2019, ended Feb 1, 2020 | 1.20B |
| FY2020, ended Jan 30, 2021 | 1.21B |
| FY2021, ended Jan 29, 2022 | 1.18B |
| FY2022, ended Jan 28, 2023 | 1.15B |
| FY2023, ended Feb 3, 2024 | 1.13B |
| FY2024, ended Feb 1, 2025 | 1.12B |
| FY2025, ended Jan 31, 2026 | 1.11B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | 1.10B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Jan 28, 2017 | $1.70B | $102M | $164M |
| FY2017, ended Feb 3, 2018 | $1.64B | $101M | $134M |
| FY2018, ended Feb 2, 2019 | $2.41B | $104M | $255M |
| FY2019, ended Feb 1, 2020 | $1.55B | $125M | $232M |
| FY2020, ended Jan 30, 2021 | $202M | $59.0M | $211M |
| FY2021, ended Jan 29, 2022 | $2.18B | $189M | $229M |
| FY2022, ended Jan 28, 2023 | $2.25B | $122M | $321M |
| FY2023, ended Feb 3, 2024 | $2.48B | $160M | $285M |
| FY2024, ended Feb 1, 2025 | $2.51B | $183M | $366M |
| FY2025, ended Jan 31, 2026 | $2.52B | $214M | $311M |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $2.80B | $223M | $341M |
Valuation
At current price- Market Cap
- $154B
- P/E
- 25.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.5×
- Price / Book
- 14.5×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $62.4B
- Revenue Growth YoY
- 7.7%
- Revenue CAGR 3Y
- 6.5%
- Revenue CAGR 5Y
- 13.4%
- EPS Growth YoY
- 23.0%
- Net Income Growth YoY
- 22.0%
Profitability
Trailing 12 months- Gross Margin
- 32.0%
- Operating Margin
- —
- Net Margin
- 9.7%
- FCF Margin
- 9.4%
- Return on Equity
- 62.2%
Earnings
Trailing 12 months- Net Income
- $6.07B
- EPS (diluted)
- $5.40
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Aug 1, 2026- Cash and cash equivalents
- $6.00B
- Total Debt
- $2.87B
- Net Cash
- $3.13B
- Total Assets
- $37.1B
- Total Liabilities
- $26.5B
- Shareholders' Equity
- $10.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $8.03B
- Capital Expenditure
- $2.16B
- Free Cash Flow
- $5.88B
Dividends and risk
Last 12 months- Dividend Yield
- 1.3%
- Dividend / Share
- $1.81
- Beta (5Y)
- 0.56
Every ratio is calculated from the company’s reported figures.